Mobley P L, Hedberg K, Bonin L, Chen B, Griffith O H
Department of Pharmacology, University of Texas Health Science Center, San Antonio 78284.
Exp Cell Res. 1994 Sep;214(1):55-66. doi: 10.1006/excr.1994.1233.
The changes in protein phosphorylation and cytoskeletal structure preceding the dramatic morphological changes in staurosporine-treated rat astrocytes were examined, and the dependence of these effects on protein kinase C (PKC) was studied. Fluorescence and photoelectron microscopy revealed that a 20-min exposure to the kinase inhibitor staurosporine at 100 nM substantially decreased the thickness and linear appearance of actin microfilament bundles (stress fibers) prior to major changes in cell shape, while 60 min of staurosporine depleted virtually all microfilament bundles and caused arborization and contraction of the cell body. The distribution of myosin light chain (MLC) labeling within the cytoplasm was also dramatically altered by staurosporine, progressing from a linear punctate pattern coincident with the linear pattern of filamentous actin to a diffuse pattern in cells in which microfilament dissolution was taking place. Two-dimensional gel analysis of astrocyte phosphoproteins demonstrated 50-80% reduction of 32P incorporation into four 20-kDa spots, one of which was recognized by an antibody to MLC, following a 15-min treatment with 100 nM staurosporine. Depletion of functinal PKC from astrocytes by a 24-h exposure to phorbol myristate acetate prior to staurosporine exposure did not reduce the extent of the cytoskeletal alterations or alter the decrease in protein phosphorylation. Two other protein kinase inhibitors which affect astrocyte morphology, H-7 and the MLC kinase inhibitor ML-9, were also observed to disrupt microfilament bundles with accompanying decreases in 32P incorporation into these same phosphoproteins, whereas the more selective PKC inhibitor Ro 31-8220 did not do either. The early onset of decreased phosphorylation of the 20-kDa proteins supports a direct relationship between the rapid dissociation of myosin light chain from actin microfilament bundles, the disruption of actin patterns, and the subsequent morphological alterations. These data also suggest that staurosporine and H-7 may exert their effects via a pathway involving inhibition of MLC kinase.
研究了星形孢菌素处理的大鼠星形胶质细胞在发生显著形态变化之前蛋白质磷酸化和细胞骨架结构的变化,并研究了这些效应对蛋白激酶C(PKC)的依赖性。荧光显微镜和光电子显微镜显示,在100 nM浓度下,用激酶抑制剂星形孢菌素处理20分钟,在细胞形状发生重大变化之前,肌动蛋白微丝束(应力纤维)的厚度和线性外观显著降低,而60分钟的星形孢菌素处理几乎耗尽了所有微丝束,并导致细胞体分支和收缩。星形孢菌素还显著改变了肌球蛋白轻链(MLC)在细胞质中的标记分布,从与丝状肌动蛋白线性模式一致的线性点状模式转变为微丝溶解细胞中的弥散模式。对星形胶质细胞磷酸化蛋白的二维凝胶分析表明,在用100 nM星形孢菌素处理15分钟后,四个20 kDa斑点中的32P掺入量减少了50-80%,其中一个斑点可被抗MLC抗体识别。在星形孢菌素处理之前,通过24小时暴露于佛波酯肉豆蔻酸酯来耗尽星形胶质细胞中的功能性PKC,并没有降低细胞骨架改变的程度,也没有改变蛋白质磷酸化的减少。还观察到另外两种影响星形胶质细胞形态的蛋白激酶抑制剂H-7和MLC激酶抑制剂ML-9,它们也会破坏微丝束,同时伴随着这些相同磷酸化蛋白中32P掺入量的减少,而更具选择性的PKC抑制剂Ro 31-8220则没有这些作用。20 kDa蛋白磷酸化减少的早期发生支持了肌球蛋白轻链从肌动蛋白微丝束快速解离、肌动蛋白模式破坏与随后形态改变之间的直接关系。这些数据还表明,星形孢菌素和H-7可能通过涉及抑制MLC激酶的途径发挥作用。